1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with scopolamine hydrobromide in 2 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 7,548 | 563 | 1,401 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | scopolamine hydrobromide (IC50) |
---|---|---|---|
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HZ; Dong, CZ; Gao, XL; Heymans, F; Huang, H; Li, J; Massicot, F; Miezan Ezoulin, JM | 1 |
Ba, MW; Chen, HZ; Chen, SD; Ding, JQ; Lu, GQ; Pan, J; Sun, ZK; Yang, HQ; Zhao, YX | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and scopolamine hydrobromide
Article | Year |
---|---|
Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity.
Topics: Acetylcholinesterase; Animals; Binding, Competitive; Brain; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Humans; In Vitro Techniques; Male; Maze Learning; Memory; Memory Disorders; Mice; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Receptors, G-Protein-Coupled; Scopolamine; Space Perception | 2007 |
PMS777, a new cholinesterase inhibitor with anti-platelet activated factor activity, regulates amyloid precursor protein processing in vitro.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Bungarotoxins; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Furans; Humans; Muscarinic Antagonists; Platelet Activating Factor; Rats; Scopolamine | 2009 |